Growing community of inventors

London, United Kingdom

Alexander Ashall-Kelly

Average Co-Inventor Count = 9.47

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Alexander Ashall-KellyJeffrey McKenna (2 patents)Alexander Ashall-KellyPaul Wright (2 patents)Alexander Ashall-KellyMahbub Ahmed (2 patents)Alexander Ashall-KellyJoseph McKenna (2 patents)Alexander Ashall-KellyLouisa Gueritz (2 patents)Alexander Ashall-KellySimon Mutton (2 patents)Alexander Ashall-KellyRakesh Parmar (2 patents)Alexander Ashall-KellyGraham Charles Bloomfield (1 patent)Alexander Ashall-KellyJon Shepherd (1 patent)Alexander Ashall-KellyJon Sheperd (1 patent)Alexander Ashall-KellyJeffrey Mckenna (0 patent)Alexander Ashall-KellyJoseph Mckenna (0 patent)Alexander Ashall-KellyAlexander Ashall-Kelly (2 patents)Jeffrey McKennaJeffrey McKenna (13 patents)Paul WrightPaul Wright (8 patents)Mahbub AhmedMahbub Ahmed (7 patents)Joseph McKennaJoseph McKenna (5 patents)Louisa GueritzLouisa Gueritz (2 patents)Simon MuttonSimon Mutton (2 patents)Rakesh ParmarRakesh Parmar (2 patents)Graham Charles BloomfieldGraham Charles Bloomfield (12 patents)Jon ShepherdJon Shepherd (1 patent)Jon SheperdJon Sheperd (1 patent)Jeffrey MckennaJeffrey Mckenna (0 patent)Joseph MckennaJoseph Mckenna (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (2 from 3,923 patents)


2 patents:

1. 9359381 - Tricyclic compounds for inhibiting the CFTR channel

2. 9303035 - Substituted pyrazino[1',2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…